| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $17.0M | +0.8% |
| SG&A Expense | $12.6M | -6.5% |
| Operating Income | -$30.4M | -0.3% |
| Income Tax | $0 | — |
| Net Income | -$30.4M | -1.4% |
| EPS (Basic) | -$0.57 | +43.0% |
| EPS (Diluted) | -$0.57 | +43.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $12.6M | -48.9% |
| Total Assets | $20.9M | -37.9% |
| Current Liabilities | $3.1M | -42.8% |
| Total Liabilities | $6.5M | -26.3% |
| Stockholders' Equity | $14.5M | -41.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.1M | -3.5% |
| Investing Cash Flow | -$187K | +68.8% |
| Financing Cash Flow | $14.2M | -47.6% |